Nutropin Depot Articles

Serono's Serostim helps lean body mass

5 April 2004

Aventis to see if Lantus reduces CVD risk

1 March 2004

Serono 2003 profits up 21.6%, beating forecasts; promises even more

9 February 2004

FDA OKs Serono's Zorbtive for SBS

8 December 2003

Serono's Serostim approved in USA for AIDS wasting

8 September 2003

Serono raises 2003 forecast; 2nd-qtr figs

4 August 2003

New use for Pfizer's Genotropin in EU

14 July 2003

Serono slams CPMP decision on Serostim

5 May 2003

Pharmacia gets US approval for acromegaly treatment Somavert

7 April 2003

Beaufour gets EU Ok for Nutropin AQ

24 March 2003

Waxman-Hatch has boosted generics, but jury still out on effects on innovators

6 January 2003

Emisphere/Lilly trial oral hGH product

12 August 2002

Eli Lilly 2nd-qtr sales decrease 9%

29 July 2002

Serono lowers full-year estimates after 2nd-qtr net decline

25 July 2002

Drugs giant Pfizer makes $60 billion all-share offer for Pharmacia

22 July 2002

Swedish pharma continues steady growth; 26.7bn kronor sales in 2001

8 July 2002

Serono's cool.click device cleared in EU

10 June 2002

Protecting pharmaceuticals from counterfeiting; a practical guide

10 June 2002

Somatropin OK for GH deficiency: UK NICE

3 June 2002

Eli Lilly exceeds $1 billion investment in capital projects and jobs

13 May 2002

FDA clears Nutropin AQ Pen

29 April 2002

Serono reports 10.4% 1st-qtr sales increase

29 April 2002

Pharmacia sales take a dip in first quarter

29 April 2002

Net income down 22% at Lilly as Prozac decline continues to hit hard

22 April 2002

Serono optimistic about 2002 on the back of Rebif launch in USA

8 April 2002

Serono launches needle-free Serostim in USA

18 February 2002

Pharmacia 4th-qtr profits take a dip but Celebrex still selling well

11 February 2002

Novo's NovoLog receives US approval for use in pumps

7 January 2002

US pharma's R&D cost claims "cannot be reconciled with its IRS filings,"

5 December 2001

Serono reports disappointing sales

31 October 2001

Pharmacia EPS rises 24% in third quarter

24 October 2001

Sharp decline in third-quarter 2001 net income for Lilly as Prozac sales

19 October 2001

Extended labeling for Serono's Saizen approved in EU

16 August 2001

Pharmacia earnings up 20%, sales rise 5%

25 July 2001

Net income at Switzerland's Serono jumps 42.5% as Rebif growth continues

24 July 2001

New drugs lift Lilly's 2nd qtr sales 16%

23 July 2001

New drugs lift Lilly's 2nd qtr sales 16%

20 July 2001

Schwarz sells back hormone rights

8 June 2001

US FDA probes counterfeit drugs

5 June 2001

Serono makes strong start to 2001

2 May 2001

Pharmacia sees 19% EPS rise and Rx pharma sales increase 15% in 1st qtr

26 April 2001

Needle-free hGH approved for HIV in USA

5 April 2001

Pharmacia acquires remainder of Sensus

8 March 2001

Profits at Switzerland's Serono jump 64.2% as royalty revenues rise

6 March 2001

Serono tests Serostim in HIV lipodystrophy

20 February 2001

Pharmacia fourth-quarter earnings jump 32%, driven by Celebrex sales

13 February 2001

Rebif pushes Serono sales up 16.2%

23 January 2001

Novo and Pharmacia settle hGH dispute

14 November 2000

Strong sales of Celebrex lead to 57% leap in earnings per share at Pharmacia

1 November 2000

Serono third-quarter earnings leap 83%

24 October 2000

EMEA adopts orphan drug designations

22 September 2000

Serono's Serostim is first EU orphan drug

14 September 2000

Pharmacia Corp sales increase 16% boosted by Celebrex and Xalatan

26 July 2000

Serono sees 2nd-qtr net income leap 60%

21 July 2000

Nutropin Depot launched in USA

29 June 2000

Needle-free hGH from Serono approved in USA

26 June 2000

US approval for Novo Nordisk's Norditropin

21 June 2000

UPDATE: Alkermes shares hit by J&J decision to drop extended-release form of

14 June 2000

Alkermes shares hit by J&J decision to drop extended-release form of EPO

13 June 2000

Two new therapies for Crohn's studied

2 June 2000

First disclosure of Aventis' early-stage R&D pipeline

23 May 2000

Aventis gains US approval for Lantus

27 April 2000

Pharmacia's EPS up 27% in 1st quarter

26 April 2000

Free share, capital raising and other proposals from Ares-Serono

20 April 2000

Ares-Serono 1999 net income soars 141%, pipeline makes future look healthy

2 March 2000

Alkermes to have eight productsin trials by year-end

17 February 2000

Pharmacia & Upjohn and Monsanto both post strong results for 1999

11 February 2000

Lilly, Alkermes team up for pulmonary hGH

9 February 2000

Analysts enthuse about Ares-Serono

4 February 2000

Novo Nordisk settles Lilly patent dispute

2 February 2000

Healthy full-year results for many US pharmaceutical companies

27 January 2000

$180M lawsuit bill hits Genentech earnings

21 January 2000

Ares-Serono sales hit $1 billion mark

19 January 2000

Genentech's Nutropin Depot approved in USA

29 December 1999

Ares-Serono says sales "on track to exceed $1 billion in 1999"

4 November 1999

P&U continues turnaround, looking for 1999 double-digit growth

29 October 1999

Genentech in patent dispute with University of California

14 October 1999

Roche reducing stake in Genentech

11 October 1999

Pharmacia & Upjohn net income up 47%

2 August 1999

Gen-eng drug market growth "to be driven by products not yet launched"

20 July 1999

Genentech sales rise thanks to Herceptin and Rituxan, takes $1.15 billion

14 July 1999

Novo seeks US go-ahead for liquid hGH (updated)

6 July 1999

Novo files for hGH liquid form in USA

2 July 1999

Genentech/Alkermes file for Nutropin Depot in USA

1 July 1999

Genentech and Alkermes; Promising Data With Nutropin Depot

17 June 1999

Pharmacia & Upjohn earnings up 17%

5 May 1999

1st qtr net income up 111% at Ares-Serono

30 April 1999

Genentech's 1st qtr product sales leap 42%

15 April 1999

Genentech fined $50 mill by US govt

15 April 1999

Novo Nordisk plans intensive product launch phase for 1999

31 March 1999

Novo liquid hGH approved in Denmark

29 March 1999

Ares-Serono's earnings beat expectations

11 March 1999

Drug delivery sector and firms profiled at BIO conference

3 March 1999

P&U posts strong growth for 1998

12 February 1999

Schwarz licenses hGH products

11 February 1999

Ares-Serono posts solid growth in 1998

19 January 1999

Serono Canada's Serostim Approved In Canada

3 December 1998

Disappointing Results For Ares-Serono

12 November 1998

Pharmacia & Upjohn Posts Strong Growth For 3rd Qtr

3 November 1998

Genentech/Alkermes To File For Nutropin Depot

27 October 1998

Showing 101-200 of 258 articles

Go to beginningPreviousNextGo to end